Product Information

LAMOTRIGINE ODT 200 MG TABLET is a generic product labeled by Endo USA Inc., priced at $1.4657 per EA under NDC 49884048711. Its NADAC has been published 492 times since Mar 22, 2017.

FDA first approved this application on Oct 27, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LAMOTRIGINE ODT 200 MG TABLET

Lamotrigine
$1.4657per EA
High Outlier

Strength

200 mg/1

Manufacturer

Endo USA Inc.

NDC

49884048711

Classification

Generic

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA204158

FDA Approved

10/27/2015

TE Code

AB

On Market Since

12/16/2015

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMOTRIGINE ODT 200 MG TABLET has been published 492 times since Mar 22, 2017, and over the history we have for it it has declined 78.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.4657 per EA
All-time high$8.2101 (Jan 10, 2018)
All-time low$1.3404 (Jul 22, 2026)
52-week high$2.5962
52-week low$1.3404
Median price$5.5345
Average price$4.9220
Largest weekly change+92.9% (Nov 22, 2023)
Weeks tracked492
Tracking sinceMar 22, 2017

Price History

1W

+9.3%

1M

+9.3%

3M

-3.4%

6M

-38.5%

1Y

-43.5%

3Y

-49.7%

5Y

-73.5%

All

-78.2%

Generic Alternatives

The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LAMOTRIGINE ODT 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ODT 200 MG TABLET, manufactured by Endo USA Inc., is $1.4657 per EA (NDC 49884048711), effective Aug 19, 2026.

How has the price of LAMOTRIGINE ODT 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMOTRIGINE ODT 200 MG TABLET has declined 78.2%. It has been tracked across 492 weekly CMS publications since Mar 22, 2017.

What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ODT 200 MG TABLET?

Since Mar 22, 2017, the NADAC for LAMOTRIGINE ODT 200 MG TABLET has ranged from a low of $1.3404 (Jul 22, 2026) to a high of $8.2101 (Jan 10, 2018), with a median of $5.5345 per EA.

Are there cheaper alternatives to LAMOTRIGINE ODT 200 MG TABLET?

Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 200 MG TABLET, is $0.0838 per EA — about 94% below LAMOTRIGINE ODT 200 MG TABLET.

Who manufactures LAMOTRIGINE ODT 200 MG TABLET?

LAMOTRIGINE ODT 200 MG TABLET (NDC 49884048711) is labeled by Endo USA Inc., and CMS classifies it as a generic product.